Robert Weiss Net Worth

The estimated Net Worth of Robert S Weiss is at least 31.4 百万$ dollars as of 1 April 2024. Mr. Weiss owns over 3,180 units of Cooper Companies stock worth over 31,028,652$ and over the last 21 years he sold COO stock worth over 0$. In addition, he makes 375,481$ as Director at Cooper Companies.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Weiss COO stock SEC Form 4 insiders trading

Robert has made over 28 trades of the Cooper Companies stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 3,180 units of COO stock worth 345,062$ on 1 April 2024.

The largest trade he's ever made was exercising 241,288 units of Cooper Companies stock on 7 March 2024 worth over 13,854,757$. On average, Robert trades about 19,114 units every 85 days since 2003. As of 1 April 2024 he still owns at least 285,952 units of Cooper Companies stock.

You can see the complete history of Mr. Weiss stock trades at the bottom of the page.

Robert Weiss biography

Robert S. Weiss has been appointed Director of the Company. Mr. Weiss served as our President from March 2008 and as our Chief Executive Officer from November 2007 until his retirement in May 2018. He also served as President of CooperVision, our contact lens subsidiary, from March 2007 to February 2008. He previously served as our Chief Operating Officer from January 2005 to October 2007 and as Executive Vice President from October 1995 to October 2007. He served as our Chief Financial Officer from September 1989 to January 2005. He served as our Treasurer from 1989 to March 2002. Since joining us in 1977, he has held a number of finance positions both with us and Cooper Laboratories, Inc. (our former parent). Mr. Weiss served as a director of Accuray Incorporated (Nasdaq: ARAY), a company that develops, manufactures, and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives, until November 2019. He served on its nominating and governance committee and on its audit committee. He is also a member of the Board of Trustees of the University of Scranton in Pennsylvania and serves on its finance, advancement, and audit committees.

What is the salary of Robert Weiss?

As the Director of Cooper Companies, the total compensation of Robert Weiss at Cooper Companies is 375,481$. There are 15 executives at Cooper Companies getting paid more, with Albert White having the highest compensation of 7,724,740$.

How old is Robert Weiss?

Robert Weiss is 73, he's been the Director of Cooper Companies since 2018. There are 2 older and 17 younger executives at Cooper Companies. The oldest executive at Cooper Companies, Inc. is A. Thomas Bender, 80, who is the Independent Chairman of the Board.

What's Robert Weiss's mailing address?

Robert's mailing address filed with the SEC is C/O THE COOPER COMPANIES, INC., 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON, CA, 94583.

Insiders trading at Cooper Companies

Over the last 21 years, insiders at Cooper Companies have traded over 45,273,696$ worth of Cooper Companies stock and bought 5,157 units worth 1,262,486$ . The most active insiders traders include Robert S Weiss、William A Kozy、Lawrence Erik Kurzius. On average, Cooper Companies executives and independent directors trade stock every 18 days with the average trade being worth of 1,325,775$. The most recent stock trade was executed by Brian G Andrews on 5 September 2024, trading 24,788 units of COO stock currently worth 939,713$.

What does Cooper Companies do?

company overview the cooper companies, inc. ("cooper"​) is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.

Complete history of Mr. Weiss stock trades at Accuray Inc、Cooper Companies

Cooper Companies executives and stock owners

Cooper Companies executives and other stock owners filed with the SEC include:

• Albert White,
  President, Chief Executive Officer, Director
• Daniel McBride,
  Chief Operating Officer, Executive Vice President, President of CooperVision, Inc.
• Holly Sheffield,
  President - CooperSurgical
• Brian Andrews,
  Chief Financial Officer, Senior Vice President, Treasurer
• Albert G. White III,
  Pres, CEO & Non-Independent Director
• Agostino Ricupati,
  Senior Vice President - Finance and Tax, Chief Accounting Officer
• Daniel G. McBride Esq.,
  Exec. VP & COO
• Holly R. Sheffield,
  Pres of CooperSurgical, Inc.
• Brian G. Andrews,
  Exec. VP, CFO & Treasurer
• A. Thomas Bender,
  Independent Chairman of the Board
• Allan Rubenstein,
  Independent Vice Chairman of the Board, Lead Director
• Jody Lindell,
  Independent Director
• Gary Petersmeyer,
  Independent Director
• Colleen Jay,
  Independent Director
• William Kozy,
  Independent Director
• Robert Weiss,
  Director
• Teresa Madden,
  Independent Director
• Kim Duncan,
  Vice President of Investor Relations and Administration
• Randal Golden,
  Vice President, General Counsel, Secretary
• Juan Carlos Aragón,
  Pres of CooperVision Specialty EyeCare Division
• Mark J. Drury,
  VP, Gen. Counsel & Corp. Sec.
• Agostino Ricupati,
  Sr. VP of Fin. & Tax and Chief Accounting Officer
• Carol R Kaufman,
  VP Legal Affairs, Sec. and CAO
• Paul L Remmell,
  COO, VP Finance-CSI
• Tina Maloney,
  Corporate Controller
• Gregory W Matz,
  VP & CFO
• Stanley Md Zinberg,
  Director
• Michael Kalkstein,
  
• Nicholas J Pichotta,
  
• Rodney Folden,
  Corporate Controller
• Donald Press,
  Director
• Steven Rosenberg,
  Director
• Jeffrey Alan Mc Lean,
  Pres - U.S. Ops - CVI
• Dennis Murphy,
  President Americas, CVI
• Moses Marx,
  Director
• Andrew Sedgwick,
  Managing Dir., Europe of CVI
• Eugene J Midlock,
  Vice President, Taxes
• John J Calcagno,
  CFO and VP Bus. Dev.
• John Arthur Weber,
  Vice Pres Worldwide Ops-CVI
• J Christopher Marmo,
  VP, R&D of CooperVision, Inc.
• John D Fruth,
  Director
• B Norris Battin,
  
• Edgar J Cummins,
  Director
• Steven M Neil,
  CFO
• David Acosta,
  Treasurer
• Companies Inc Cooper,
  Director
• Gregory A Fryling,
  COO - CVI
• James M Welch,
  Vice President Intl Ops - CVI
• Stephen Whiteford,
  VP, Corporate Controller
• Robert D Auerbach,
  Special Advisor to the CEO
• Mark J Drury,
  VP, General Counsel & Sec.
• Maria Rivas,
  
• Gerard H Iii Warner,
  President, CooperVision, Inc.
• Nicholas Khadder,
  VP, General Counsel & Corp Sec
• Lawrence Erik Kurzius,
  
• Cynthia L Lucchese,